Spinal muscular atrophy counteracted by Agrin biological NT-1654
Article Sidebar
Main Article Content
Abstract
Spinal muscular atrophy (SMA) is a genetic and gravely disease, portrayed by motor neuron (MN) death, thereby leading to progressive and accelerating muscle fragility, respiratory collapse, and, in the most severe cases, it even pave the way to death. At the neuromuscular junction (NMJ), abnormally have been reported in SMA, including neurofilament (NF) aggregation at presynaptic terminals, immature and smaller endplates, lowered transmitter release, and, eventually, muscle denervation. In this review the role of Agrin in SMA is studied. This review highlights the antagonizing role of Agrin in SMA.
Article Details
Copyright (c) 2018 Paul J.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Boido M, Amicis DE, Valsecchi V, Trevisan M, Ala U, et al. Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy. Front Cell Neurosci. 2018; 12: 17. Ref.: https://goo.gl/FEknfJ
Martínez-Hernández R, Bernal S, Also-Rallo E, Alías L, Barceló MJ, et al. Synaptic defects in type I spinal muscular atrophy in human development. J Pathol. 2013; 229: 49-61. Ref.:https://goo.gl/V4Ydrg
Lorson CL, Rindt H, Shababi M. Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet. 2010; 19: 111-118. Ref.: https:1//goo.gl/d3QAtt
Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997; 16: 265-269. Ref.: https://goo.gl/gRXxvn
Bolliger MF, Zurlinden A, Lüscher D, Bütikofer L, Shakhova O, et al. Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junction. J Cell Sci. 2010; 123: 3944-3955. Ref.: https://goo.gl/ACU7Hx
Kolb SJ, Battle DJ, Dreyfuss G. Molecular functions of the SMN complex. J Child Neurol. 2007; 22: 990-994. Ref.: https://goo.gl/R3CcFq
Tsai LK. Therapy development for spinal muscular atrophy in SMN independent targets; Neural Plast. 2012. Ref.: https://goo.gl/QZiKhf
Murray LM, Talbot K, Gillingwater TH. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy; Neuropathol Appl Neurobiol. 2010; 36: 133-156. Ref.: https://goo.gl/ByUVCK
Goulet BB, Kothary R, Parks RJ. At the “junction” of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression. Curr Mol Med. 2013; 13: 1160-1174. Ref.: https://goo.gl/ifcPYF
Ling KKY, Lin MY, Zingg B, Feng Z, Ko CP. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS ONE. 2010; 5:Ref.: https://goo.gl/5rsNzH
Valsecchi V, Boido M, Amicis ED, Piras A, Vercelli A. Expression of muscle-specific miRNA 206 in the progression of disease in a murine SMA model. PLoS One 2015; 10: Ref.: https://goo.gl/hWd8oK
Li Z, Li M, Wood K, Hettwer S, Muley SA, et al. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis. Muscle Nerve. 2017. Ref.: https://goo.gl/eU2taQ